Centessa Pharmaceuticals plc (NASDAQ: CNTA)
$16.4250
+0.1450 ( +0.77% ) 236.5K
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
Market Data
Open
$16.4250
Previous close
$16.2800
Volume
236.5K
Market cap
$2.15B
Day range
$6.5310 - $16.6000
52 week range
$6.5310 - $18.9700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Jun 25, 2024 |
| 3 | Insider transactions | 2 | Jun 17, 2024 |
| 8-k | 8K-related | 17 | Jun 10, 2024 |
| 10-q | Quarterly Reports | 67 | May 13, 2024 |
| 8-k | 8K-related | 16 | May 13, 2024 |
| ars | Annual reports | 1 | May 09, 2024 |
| def | Proxies and info statements | 7 | May 09, 2024 |
| pre | Proxies and info statements | 7 | Apr 26, 2024 |
| 8-k | 8K-related | 19 | Apr 24, 2024 |
| 8-k | 8K-related | 56 | Apr 22, 2024 |